SUPN:NASDAQ
Supernus, Inc.
$36.28
0.00%
(0.00) 1D
$36.41
arrow_upward
+0.36% (+0.13)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUPN...
Mkt. cap
6.17B
Avg. vol.
2.44M
Volume
0.00
P/E ratio
13.06
52-wk high
$42.81
52-wk low
$27.68
EPS
$2.78
Beta
1.10
Shares outstanding
118.04M
No. of employees
778
Mkt. cap
6.17B
Avg. vol.
2.44M
Volume
0.00
P/E ratio
13.06
52-wk high
$42.81
52-wk low
$27.68
EPS
$2.78
Beta
1.10
Shares outstanding
118.04M
No. of employees
778
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
Nasdaq
·
1 day ago
Chartstopper: November 13, 2026
Bloomberg.com
·
9 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Supernus, Inc.
CEOJack A. Khattar | Mark Crossley
Employees778
FoundedSep 26, 2014
HeadquartersRockville, Maryland, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteindivior.com